{
    "cit1": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Since the discovery of tRNA degradation products in sera and urine of cancer patients (1, 2), numerous tRNA fragments (tRFs) were reported to be present in diverse organisms (3).",
        "REFERENCE": "(1,",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit2": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Since the discovery of tRNA degradation products in sera and urine of cancer patients (1, 2), numerous tRNA fragments (tRFs) were reported to be present in diverse organisms (3).",
        "REFERENCE": "2)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit3": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Since the discovery of tRNA degradation products in sera and urine of cancer patients (1, 2), numerous tRNA fragments (tRFs) were reported to be present in diverse organisms (3).",
        "REFERENCE": "(3)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit4": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recent deep sequencing of small RNA libraries from various human cancer tissues and cell lines has identified diverse types of tRFs derived from precursor tRNAs (pre-tRNAs) and mature tRNAs (4) (5) (6) (7) (8).",
        "REFERENCE": "(4)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit5": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recent deep sequencing of small RNA libraries from various human cancer tissues and cell lines has identified diverse types of tRFs derived from precursor tRNAs (pre-tRNAs) and mature tRNAs (4) (5) (6) (7) (8).",
        "REFERENCE": "(5)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit6": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recent deep sequencing of small RNA libraries from various human cancer tissues and cell lines has identified diverse types of tRFs derived from precursor tRNAs (pre-tRNAs) and mature tRNAs (4) (5) (6) (7) (8).",
        "REFERENCE": "(6)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit7": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recent deep sequencing of small RNA libraries from various human cancer tissues and cell lines has identified diverse types of tRFs derived from precursor tRNAs (pre-tRNAs) and mature tRNAs (4) (5) (6) (7) (8).",
        "REFERENCE": "(7)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit8": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recent deep sequencing of small RNA libraries from various human cancer tissues and cell lines has identified diverse types of tRFs derived from precursor tRNAs (pre-tRNAs) and mature tRNAs (4) (5) (6) (7) (8).",
        "REFERENCE": "(8)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit9": {
        "SECTION": "INTRODUCTION",
        "CITATION": "As evidenced by precise terminal sequences of some of those small RNAs (smRNAs), including tRFs [tRFs representing the 5 -end (tRF 5) or 3 -end (tRF 3) region of mature tRNA] and tRNA-derived stress-induced RNAs (also named tiRNAs or tRNA-halves generated by angiogenin-mediated cleavage at the tRNA anticodon region), and by the presence of distinct sets of tRFs in different cell types, these tRFs appear to be produced by controlled cellular processes (9).",
        "REFERENCE": "(9)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit10": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(9)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit11": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(10)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit12": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(11)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit13": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(12)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit14": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(13)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit15": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(14)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit16": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(15)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit17": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(16)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit18": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Recently, mature tRNA-derived tRFs, which were previously regarded as merely degradation intermediates, have emerged as potential effectors implicated in cancer development, regulation of translation and target gene expression, metabolic and neurological disorders, epigenetic inheritance and ribosome biogenesis (9) (10) (11) (12) (13) (14) (15) (16) (17).",
        "REFERENCE": "(17)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit19": {
        "SECTION": "INTRODUCTION",
        "CITATION": "For instance, some of tiRNAs and tRFs derived from 5 end of tRNA were shown to possess translation suppressing activity (8, 18).",
        "REFERENCE": "(8,",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit20": {
        "SECTION": "INTRODUCTION",
        "CITATION": "For instance, some of tiRNAs and tRFs derived from 5 end of tRNA were shown to possess translation suppressing activity (8, 18).",
        "REFERENCE": "18)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit21": {
        "SECTION": "INTRODUCTION",
        "CITATION": "tRFs derived from the 3 end of certain mature tRNAs were proposed to act as a primer for reverse transcriptase of T-cell leukemia virus type 1 and to target the primer-binding site of HIV-1 to suppress viral replication (19, 20).",
        "REFERENCE": "(19,",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit22": {
        "SECTION": "INTRODUCTION",
        "CITATION": "tRFs derived from the 3 end of certain mature tRNAs were proposed to act as a primer for reverse transcriptase of T-cell leukemia virus type 1 and to target the primer-binding site of HIV-1 to suppress viral replication (19, 20).",
        "REFERENCE": "20)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit23": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Wang et al. (21) demonstrated antiviral activity of angiogenin-cleaved tRFs accumulating in respiratory syncytial virus-infected cells.",
        "REFERENCE": "Wang et al. (21)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit24": {
        "SECTION": "INTRODUCTION",
        "CITATION": "Yet, little is known about the potential roles of pre-tRNA trailers (also called tRF-1 or tRF U3 family tRFs in this study), which are supposed to be degraded after being released during pre-tRNA processing (13), in viral life cycle.",
        "REFERENCE": "(13)",
        "ALIGNED SECTION": [
            "Introduction"
        ]
    },
    "cit25": {
        "SECTION": "Small RNA deep sequencing and bioinformatic analysis",
        "CITATION": "The reads (≥ 10 reads) were mapped to the human genome reference sequence (assembly hg19) in the University of California Santa Cruz (UCSC) Genome Browser (22) using the Bowtie (version 1.0.1) software.",
        "REFERENCE": "(22)"
    },
    "cit26": {
        "SECTION": "Small RNA deep sequencing and bioinformatic analysis",
        "CITATION": "Short sequencing reads (≥16 nt) from the La PAR-CLIP (photoactivatable ribonucleosideenhanced crosslinking and immunoprecipitation) assay datasets (GSE95683) were aligned using the Bowtie software (23) to the tRF U3 family tRFs with the allowance of two mismatches.",
        "REFERENCE": "(23)"
    },
    "cit27": {
        "SECTION": "Establishment of tRF U3 1 and La/SSB knockout cell lines",
        "CITATION": "tRF U3 1 and La/SSB knockout Huh7 cell lines were generated using the CRISPR-Cas9 genome editing system as described previously (24).",
        "REFERENCE": "(24)"
    },
    "cit28": {
        "SECTION": "Virus infection",
        "CITATION": "Huh7 cells were infected with cell culture-derived hepatitis C virus (HCVcc) by adsorption for 12 h as previously described (25).",
        "REFERENCE": "(25)"
    },
    "cit29": {
        "SECTION": "Virus infection",
        "CITATION": "Murine norovirus 1 (MNV-1) strain CW1 (kindly provided by Prof. Herbert Virgin IV, Washington University School of Medicine, St. Louis, MO, USA) was propagated in RAW264.7 cells (26).",
        "REFERENCE": "(26)"
    },
    "cit30": {
        "SECTION": "Virus infection",
        "CITATION": "Plaque forming assay for MNV-1 was performed as described previously (27).",
        "REFERENCE": "(27)"
    },
    "cit31": {
        "SECTION": "Quantification of viral RNAs, mRNAs, and small RNAs",
        "CITATION": "MicroRNA (miRNA) expression was quantified by TaqMan probe-based real-time PCR assays (Applied Biosystems, Foster, CA, USA) as described previously (28).",
        "REFERENCE": "(28)"
    },
    "cit32": {
        "SECTION": "Profile of tRFs derived from pre-tRNA 3 trailers in the HCC cell line Huh7",
        "CITATION": "Its expression level was comparable to miR-122 copy number determined by RT-PCR (1.5 × 10 4 copies/cell) (28) or RNase protection assay (1.6 × 10 4 copies/cell) (29) in Huh7.",
        "REFERENCE": "(28)"
    },
    "cit33": {
        "SECTION": "Profile of tRFs derived from pre-tRNA 3 trailers in the HCC cell line Huh7",
        "CITATION": "Its expression level was comparable to miR-122 copy number determined by RT-PCR (1.5 × 10 4 copies/cell) (28) or RNase protection assay (1.6 × 10 4 copies/cell) (29) in Huh7.",
        "REFERENCE": "(29)"
    },
    "cit34": {
        "SECTION": "Profile of tRFs derived from pre-tRNA 3 trailers in the HCC cell line Huh7",
        "CITATION": "Of these miRNAs found to be upregulated in liver cancer tissues, miR-221-3p is widely accepted as a liver cancer miRNA marker (30).",
        "REFERENCE": "(30)"
    },
    "cit35": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "The bound protein was identified as the La/SSB (Sj ögren syndrome antigen B, also known as LARP3 and La autoantigen) (31, 32) by nano LC-MS/MS analysis (Supplementary Figure S4A).",
        "REFERENCE": "(31,"
    },
    "cit36": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "The bound protein was identified as the La/SSB (Sj ögren syndrome antigen B, also known as LARP3 and La autoantigen) (31, 32) by nano LC-MS/MS analysis (Supplementary Figure S4A).",
        "REFERENCE": "32)"
    },
    "cit37": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "We next confirmed this specific interaction between tRF U3 1 and La/SSB in cells using a photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) assay (33) (Figure 2B).",
        "REFERENCE": "(33)"
    },
    "cit38": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "tRF U3 1 was abundantly detected in the UV-crosslinked RNA-La/SSB complexes, whereas miR-122, a miRNA with highest abundance in human liver tissue (28) and three other miR-NAs (miR-221, miR-23b and miR-26a) were not found in the complexes, indicating that tRF U3 1 interacts with La/SSB with a high degree of specificity.",
        "REFERENCE": "(28)"
    },
    "cit39": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "Using a similar PAR-CLIP assay in HEK293 cells transiently expressing the Flag-tagged La/SSB, Gogakos et al. (34) have recently identified several La/SSB-associated RNAs.",
        "REFERENCE": "(34)"
    },
    "cit40": {
        "SECTION": "La/SSB binds and stabilizes tRF U3 1",
        "CITATION": "Following detection of tRF U3 1 in this cell line (Figure 2E), we subsequently analyzed the deep-sequencing datasets generated by Gogakos et al. (34) and found that tRF U3 1 comprises the most abundant tRF U3 family tRFs among the reads in the dataset derived from the RNaseA-treated La/SSB-RNA crosslinked sample (Figure 2F).",
        "REFERENCE": "(34)"
    },
    "cit41": {
        "SECTION": "tRF U3 1 negatively regulates HCV IRES-mediated translation",
        "CITATION": "The RNA chaperone La/SSB was previously demonstrated to bind to the stem-loop IV of HCV internal ribosome entry site (IRES) to promote IRES-mediated translation initiation (35).",
        "REFERENCE": "(35)"
    },
    "cit42": {
        "SECTION": "tRF U3 1 negatively regulates HCV IRES-mediated translation",
        "CITATION": "The duplex form of miR-122 increased subgenomic RNA levels, which was consistent with previous findings (36).",
        "REFERENCE": "(36)"
    },
    "cit43": {
        "SECTION": "tRF U3 1 negatively regulates HCV IRES-mediated translation",
        "CITATION": "The antiviral activity of tRF U3 1 against HCV was attenuated specifically by a tRF U3 1-targeting antisense peptide nucleic acid (PNA), whereas the PNA-SL3-17 targeting the HCV X-RNA at the 3/-end of the viral genome (37) decreased HCV subgenomic replicon RNA and NS5B protein levels (Supplementary Figure S8B).",
        "REFERENCE": "(37)"
    },
    "cit44": {
        "SECTION": "tRF U3 1 negatively regulates HCV IRES-mediated translation",
        "CITATION": "By contrast, its 5triphosphate form, which is expected to be recognized by RIG-I, a cytoplasmic pattern recognition receptor for 5triphosphate single strand RNA (38, 39), and the constitutively active IRF3, IRF3 5D used as a positive control increased the reporter expression.",
        "REFERENCE": "(38,"
    },
    "cit45": {
        "SECTION": "tRF U3 1 negatively regulates HCV IRES-mediated translation",
        "CITATION": "By contrast, its 5triphosphate form, which is expected to be recognized by RIG-I, a cytoplasmic pattern recognition receptor for 5triphosphate single strand RNA (38, 39), and the constitutively active IRF3, IRF3 5D used as a positive control increased the reporter expression.",
        "REFERENCE": "39)"
    },
    "cit46": {
        "SECTION": "tRF U3 1 modulates La/SSB-dependent viral gene expression",
        "CITATION": "These results are in agreement with previous reports demonstrating the La/SSBdependent PV IRES-mediated translation in rabbit reticulocyte lysates or La/SSB-depleted HeLa cells (40, 41).",
        "REFERENCE": "(40,"
    },
    "cit47": {
        "SECTION": "tRF U3 1 modulates La/SSB-dependent viral gene expression",
        "CITATION": "These results are in agreement with previous reports demonstrating the La/SSBdependent PV IRES-mediated translation in rabbit reticulocyte lysates or La/SSB-depleted HeLa cells (40, 41).",
        "REFERENCE": "41)"
    },
    "cit48": {
        "SECTION": "tRF U3 1 modulates La/SSB-dependent viral gene expression",
        "CITATION": "Moreover, tRF U3 1 exerted its antiviral activity against norovirus whose RNA genome interacts with La/SSB at its 5 and 3 ends (42).",
        "REFERENCE": "(42)"
    },
    "cit49": {
        "SECTION": "DISCUSSION",
        "CITATION": "In addition, these trailer sequences, unlike tRFs derived from mature tRNAs, can be correctly annotated to corresponding pre-tRNA-coding genes because base modifications, which occur in the D-loop or TC loop and thereby can introduce unwanted mutations during cDNA synthesis, are not present on this tail part of pre-tRNA (13).",
        "REFERENCE": "(13)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit50": {
        "SECTION": "DISCUSSION",
        "CITATION": "Our results recapitulated the positive regulatory role of La/SSB in HCV and PV IRES-mediated trans-lation (35, 43, 44).",
        "REFERENCE": "(35,",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit51": {
        "SECTION": "DISCUSSION",
        "CITATION": "Our results recapitulated the positive regulatory role of La/SSB in HCV and PV IRES-mediated trans-lation (35, 43, 44).",
        "REFERENCE": "43,",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit52": {
        "SECTION": "DISCUSSION",
        "CITATION": "Our results recapitulated the positive regulatory role of La/SSB in HCV and PV IRES-mediated trans-lation (35, 43, 44).",
        "REFERENCE": "44)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit53": {
        "SECTION": "DISCUSSION",
        "CITATION": "For example, La/SSB binding to a specific hepatitis B virus (HBV) cis-acting element was shown to enhance HBV RNA stability (45).",
        "REFERENCE": "(45)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit54": {
        "SECTION": "DISCUSSION",
        "CITATION": "For HIV, trans-activation response element (TAR) RNA-La/SSB complex formation was shown to relieve translational repression by the 5 leader sequence of the TAR (46).",
        "REFERENCE": "(46)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit55": {
        "SECTION": "DISCUSSION",
        "CITATION": "Nowadays, it is widely accepted that La/SSB helps to ensure proper folding of pre-tRNA by binding to the 3 -end trailer and 5 -end region that facilitates tRNA processing in yeast (47, 48).",
        "REFERENCE": "(47,",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit56": {
        "SECTION": "DISCUSSION",
        "CITATION": "Nowadays, it is widely accepted that La/SSB helps to ensure proper folding of pre-tRNA by binding to the 3 -end trailer and 5 -end region that facilitates tRNA processing in yeast (47, 48).",
        "REFERENCE": "48)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit57": {
        "SECTION": "DISCUSSION",
        "CITATION": "It may also act as a transcription termination factor for RNA polymerase III (49).",
        "REFERENCE": "(49)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit58": {
        "SECTION": "DISCUSSION",
        "CITATION": "Although La/SSB mice were embryonic lethal (50), we could successfully establish the La/SSB KO Huh7 cell lines.",
        "REFERENCE": "(50)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit59": {
        "SECTION": "DISCUSSION",
        "CITATION": "Alternatively, this might be due to steric hindrance of La binding imposed by tRNA processing proteins such as RNase P and RNase Z (47, 48).",
        "REFERENCE": "(47,",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit60": {
        "SECTION": "DISCUSSION",
        "CITATION": "Alternatively, this might be due to steric hindrance of La binding imposed by tRNA processing proteins such as RNase P and RNase Z (47, 48).",
        "REFERENCE": "48)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit62": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, tRF U3 1 was also identified, albeit with different names, in various human transformed cell lines [tRF-1001 from prostate cancer cell lines (5), 3 -trailer of tRNA-Ser(TGA) from the human nasopharyngeal carcinoma 5-8F cell line (7), Cand45 from HEK293 cells (6), and Eym65 from the clonal lymphoma cell line BCP-1 (4)].",
        "REFERENCE": "(5)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit63": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, tRF U3 1 was also identified, albeit with different names, in various human transformed cell lines [tRF-1001 from prostate cancer cell lines (5), 3 -trailer of tRNA-Ser(TGA) from the human nasopharyngeal carcinoma 5-8F cell line (7), Cand45 from HEK293 cells (6), and Eym65 from the clonal lymphoma cell line BCP-1 (4)].",
        "REFERENCE": "(7)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit64": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, tRF U3 1 was also identified, albeit with different names, in various human transformed cell lines [tRF-1001 from prostate cancer cell lines (5), 3 -trailer of tRNA-Ser(TGA) from the human nasopharyngeal carcinoma 5-8F cell line (7), Cand45 from HEK293 cells (6), and Eym65 from the clonal lymphoma cell line BCP-1 (4)].",
        "REFERENCE": "(6)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit65": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, tRF U3 1 was also identified, albeit with different names, in various human transformed cell lines [tRF-1001 from prostate cancer cell lines (5), 3 -trailer of tRNA-Ser(TGA) from the human nasopharyngeal carcinoma 5-8F cell line (7), Cand45 from HEK293 cells (6), and Eym65 from the clonal lymphoma cell line BCP-1 (4)].",
        "REFERENCE": "(4)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit66": {
        "SECTION": "DISCUSSION",
        "CITATION": "Aside from its impact on viral gene expression through a direct interaction with La/SSB, tRF U3 1 abundantly expressed in various cell types may alter miRNA expression by binding and inhibiting La/SSB, because La/SSB is known to facilitate the biogenesis of miRNAs by binding to pre-miRNA stem-loop structures (32).",
        "REFERENCE": "(32)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit67": {
        "SECTION": "DISCUSSION",
        "CITATION": "Over the last 10 years, numerous studies have demonstrated regulatory roles of miRNAs in virus replication and pathogenesis (51).",
        "REFERENCE": "(51)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit68": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, some of tRF 3 or tRF 5 family tRFs were shown to be associated with various Ago proteins (17, 52).",
        "REFERENCE": "(17,",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    },
    "cit69": {
        "SECTION": "DISCUSSION",
        "CITATION": "Previously, some of tRF 3 or tRF 5 family tRFs were shown to be associated with various Ago proteins (17, 52).",
        "REFERENCE": "52)",
        "ALIGNED SECTION": [
            "Discussion"
        ]
    }
}